May 11, 2021 / 07:30AM GMT
Operator
Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)
Now we start the conference. Ms. Ohyabu, please go ahead.
Takako Ohyabu - Takeda Pharmaceutical Company Limited - Chief Global Corporate Affairs Officer
[Interpreted] Thank you very much for joining us in this FY 2020 Earnings Conference Call. I serve as a moderator today, Chief Global Corporate Affairs Officer, Takako Ohyabu.
Before we start, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in the most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of today's presentation.
Today from our side, we have presenters and the discussions in the Q&A session, President and CEO, Christophe Weber; and Chief Financial
Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Press Conference Transcript
May 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers